Prot# CYC682-06: A Randomized Phase II Study of Oral Sapacitabine in Elderly Patients with Acute Myeloid Leukemia Previously Untreated or in First Relapse

Project: Research project

Project Details

StatusFinished
Effective start/end date9/8/0810/7/18

Funding

  • Cyclacel Pharmaceuticals, Inc. (CYC682-06)